AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Fleming, GF Fowler, JM Waggoner, SE Copeland, LJ Greer, BE Horowitz, I Sutton, G Schilder, RJ Fracasso, PM Ball, HG McGuire, WP
Citation: Gf. Fleming et al., Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: A Gynecologic Oncology Group Study, J CL ONCOL, 19(4), 2001, pp. 1021-1029

Authors: Dachman, AH Visweswaran, A Battula, R Jameel, S Waggoner, SE
Citation: Ah. Dachman et al., Role of chest CT in the follow-up of ovarian adenocarcinoma, AM J ROENTG, 176(3), 2001, pp. 701-705

Authors: Mundt, AJ McBride, R Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy, INT J RAD O, 50(5), 2001, pp. 1145-1153

Authors: Mundt, AJ Murphy, KT Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma, INT J RAD O, 50(5), 2001, pp. 1154-1160

Authors: Fleming, GF Waggoner, SE Rotmensch, J Langhauser, C
Citation: Gf. Fleming et al., Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel, AM J CL ONC, 24(1), 2001, pp. 52-57

Authors: Prokopczyk, B Trushin, N Leszczynska, J Waggoner, SE El-Bayoumy, K
Citation: B. Prokopczyk et al., Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via a-hydroxylation and carbonyl reduction pathways, CARCINOGENE, 22(1), 2001, pp. 107-114

Authors: Mundt, AJ Roeske, JC Lujan, AE Yamada, SD Waggoner, SE Fleming, G Rotmensch, J
Citation: Aj. Mundt et al., Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 456-463

Authors: Mundt, AJ Rotmensch, J Waggoner, SE Yamada, D Langhauser, C Fleming, GF
Citation: Aj. Mundt et al., Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies, GYNECOL ONC, 82(2), 2001, pp. 333-337

Authors: Ashman, JB Connell, PP Yamada, D Rotmensch, J Waggoner, SE Mundt, AJ
Citation: Jb. Ashman et al., Outcome of endometrial carcinoma patients with involvement of the uterine serosa, GYNECOL ONC, 82(2), 2001, pp. 338-343

Authors: Roeske, JC Lujan, A Rotmensch, J Waggoner, SE Yamada, D Mundt, AJ
Citation: Jc. Roeske et al., Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies, INT J RAD O, 48(5), 2000, pp. 1613-1621

Authors: Rotmensch, J Connell, PP Yamada, D Waggoner, SE Mundt, AJ
Citation: J. Rotmensch et al., One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy, GYNECOL ONC, 78(1), 2000, pp. 32-38

Authors: Matthews, AK Aikens, JE Helmrich, SP Anderson, DD Herbst, AL Waggoner, SE
Citation: Ak. Matthews et al., Sexual functioning and mood among long-term survivors of clear-cell adenocarcinoma of the vagina or cervix, J PSYCH ONC, 17(3-4), 1999, pp. 27-45
Risultati: 1-12 |